A petition presented to the Supreme Court on May 1, 2024, requests the formation of a medical panel to assess the safety risks associated with the Covishield vaccine. Advocating for an expert-led examination, the plea highlights concerns over increased instances of heart attacks and sudden collapses post-vaccination, referencing revelations made in a UK court document by AstraZeneca, the vaccine’s developer. Acknowledging AstraZeneca’s disclosure of a potential link between Covishield and Thrombosis with Thrombocytopenia Syndrome (TTS), the petition emphasizes the need for thorough investigation. Additionally, the plea urges the establishment of a ‘Vaccine Damage Payment System’ for affected citizens and families, along with stringent measures to combat the circulation of counterfeit vaccines.